EUVIMEDEUVIMED entdecken
Systematische Übersicht

Novel Therapies on the Horizon of Hypertension Management

Olivia Blazek, George L Bakris iD

American Journal of Hypertension · 13.02.2023 · 36 (2) · 73-81

DOI: 10.1093/ajh/hpac111 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift American Journal of Hypertension, online erschienen am 06.10.2022. Verfasst von Olivia Blazek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, American Heart Association Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Hypertension. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 73 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The rates of uncontrolled hypertension, along with downstream cardiovascular outcomes, has been worsening in this country. Despite the plethora of antihypertensive medications on the market, the prevalence of resistant hypertension (RH) is estimated to be 13.7%. Therefore in addition to increased clinical education and focus on lifestyle management of hypertension and medication compliance, new therapies are needed to address this rise in hypertension.

Methods

A systematic review of the available medical literature was performed to identify emerging treatment options for RH.

Results

Six different pharmacologic classes and 2 procedural interventions were identified as being appropriate for review in this paper. The pharmacologic classes to be explored are non-steroidal mineralocorticoid receptor antagonists, aminopeptidase A inhibitors, dual endothelin antagonists, aldosterone synthetase inhibitors, atrial natriuretic peptide inhibitors, and attenuators of hepatic angiotensinogen. Discussion of procedural interventions to lower blood pressure will focus on renal denervation and devices that increase carotid baroreceptor activity.

Conclusions

Promising medication and procedural interventions are being developed and studied to expand our treatment arsenal for patients with uncontrolled essential hypertension and RH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionHumansAntihypertensive AgentsBlood PressureKidneyPressoreceptors

Stichwörter der Autor:innen

aldosteroneaminopeptidaseblood pressureendothelinhypertensionnovel therapy

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Medicine, American Heart Association Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, IL 60637, USA.

ORCID-Profile: George L Bakris

Zitieren

APA

Blazek, O., & Bakris, G. L. (2023). Novel Therapies on the Horizon of Hypertension Management. American Journal of Hypertension, 36(2), 73-81. https://doi.org/10.1093/ajh/hpac111

Vancouver

Blazek O, Bakris GL. Novel Therapies on the Horizon of Hypertension Management. American Journal of Hypertension. 2023;36(2):73-81. doi:10.1093/ajh/hpac111

BibTeX
@article{Blazek2023,
  author = {Blazek, Olivia and Bakris, George L},
  title = {Novel Therapies on the Horizon of Hypertension Management},
  journal = {American Journal of Hypertension},
  year = {2023},
  volume = {36},
  number = {2},
  pages = {73--81},
  doi = {10.1093/ajh/hpac111}
}
Kostenlos starten →